Dengue is a highly endemic infectious disease of the tropical countries and is rapidly
becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is …

Dengue viral infection has become an increasing global health concern with over two-fifths
of the world's population at risk of infection. It is the most rapidly spreading vector borne …

Challenges associated with the interference observed between the dengue virus
components within early tetravalent live-attenuated vaccines led many groups to explore the …

Dengue fever (DF), the most prevalent arthropod-borne viral illness in humans, is caused by
the dengue virus (DENV). The 4 serotypes of DENV (DENV 1-4) are transmitted to humans …

A dengue vaccine should induce long-lasting, simultaneous protection to the four dengue
viruses while avoiding the immune enhancement of viral infection. Domain III of the dengue …

We have previously reported the construction and evaluation in mice of recombinant fusion
proteins formed by a fragment (aa 286–426) of the dengue envelope protein and the P64k …

Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and
subtropical regions, causing hundreds of millions of infections each year. Infections range …

Each of the DENV serotypes can cause the full spectrum of dengue illness. Epidemiological
studies have implicated preexisting heterotypic DENV antibody as a risk factor for more …

There is currently no vaccine to prevent dengue (DEN) virus infection, which is caused by
any one of four closely related serotypes, DEN-1, DEN-2, DEN-3, or DEN-4. A DEN vaccine …

Dengue disease is an increasing global health problem that threatens one-third of the
world's population. To control this emerging arbovirus, an efficient preventive vaccine is still …